Skip to main content

Table 3 OS of all patients, Child A and Child B/C subgroups and patients with/without portal invasion

From: Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

  cTACE (n = 174) DEB-TACE (n = 76) p
OS (days) median (CI) median (CI)  
All patients 409 (321–488) 369 (310–589) 0.76
Child A 602 (484–792) 627 (364–788) 0.40
Child B/C 223 (165–315) 226 (114–335) 0.53
Portal invasion    
Yes 221 (143–285) 194 (97–310) 0.82
No 501 (410–607) 386 (325–634) 0.48
  1. OS overall survival, CI confidence interval, DEB-TACE drug-eluting bead transarterial chemoembolization, cTACE conventional TACE